ResearcherChonnam National UniversityNo recent work listed

Hyung-Seok Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8297-9747; OpenAlex author ID A5100642358. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper

Papers 2

Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome. Last author PMID 25916042 ↗
Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance. Co-author PMID 23071857 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jung Chul Kim · 1 shared paper, 2015 · strength 0.06
- Paper Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor … PMID 25916042 ↗
Yasufumi Sato · 1 shared paper, 2015 · strength 0.06
- Paper Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor … PMID 25916042 ↗
Jung-Chul Kim · 1 shared paper, 2012 · strength 0.04
- Paper Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance. PMID 23071857 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.